Valetudo Therapeutics LLC - 10%+ Owner at Liminatus Pharma, Inc.

Issuer-level insider activity

Role: 10%+ Owner
Issuer ticker: LIMN, LIMNW on Nasdaq
Entity type: Company
Source filing history: Open source filing history

No buys or sells have been reported by Valetudo Therapeutics LLC since 16 Aug 2025

Reported holdings for Valetudo Therapeutics LLC in Liminatus Pharma, Inc.

Form 4 holding 10%+ Owner

Liminatus Pharma, Inc.

Security class: Series A Preferred Stock, par value $0.0001 per share
Shares / value: 48,975
Estimated value: $68,565,150
Report date: 02 Jul 2026
Price: $1400.00
Ownership: Direct
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount: 489,751,074

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Liminatus Pharma, Inc.

Security class: Series A Preferred Stock, par value $0.0001 per share
Shares / value: 48,975
Estimated value: $68,565,150
Report date: 02 Jul 2026
Price: $1400.00
Ownership: Direct
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount: 489,751,074

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Liminatus Pharma, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 5,244,351
Estimated value: $901,503
Report date: 02 Jul 2026
Price: $0.1719
Ownership: Direct

Form 4 holding 10%+ Owner

Liminatus Pharma, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 5,244,351
Estimated value: $901,503
Report date: 02 Jul 2026
Price: $0.1719
Ownership: Direct

Transaction history for Valetudo Therapeutics LLC in Liminatus Pharma, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .